Shire officially in play after $46B AbbVie offer
June 20, 2014 at 02:32 AM EDT
Shire, the FTSE 100 pharmaceutical company which has often been the subject of bid speculation, has rejected a takeover bid from U.S. company AbbVie.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.